Publicaciones I.E.N. Endocrinología Clínica XVII

De Luis DA, Aller R Izaola O, Primo D, Effect of polymorphism rs10830963 MTNR1B and dietary fat composition on insulin resistance after 3-month weight loss Endocrinol Diabetes Nutr. 2020 67: 43-52. FI1,26

Garcia Calvo S, Diaz Soto G, Torres Torres B, Lopez Gomez JJ, Villar Bonet A, Serrano Valles C, Jimenez Sahagun R and Luis D. Assessment of metabolic control, cardiovascular profile and adherence to the Mediterranean diet of a cohort of familial hypercholesterolemia in a public health program Nutricion Hospitalaria 2020; 37: 543-548 FI 1,305

JR Prieto, J Alonso, I Fierro, D Pacheco, D de Luis, J Aldecoa. Variations in ultrasound after bariatric surgery. Biliopancreatic diversion vs vertical gastrectomy. Hospital Nutrition 2020; 37: 474-482 FI 1.305

Rocío Aller, Rebeca Sigüenza, María Pina, Cristina Laserna, Beatriz Antolín, Beatriz Burgueño, Miguel Durà, Olatz Izaola, David Primo, De Luis D. Insulin Resistance Is Related With Liver Fibrosis in Type 2 Diabetic Patients With Non-Alcoholic Fatty Liver Disease Proven Biopsy and Mediterranean Diet Pattern as a Protective Factor. Endocrine 2020; 68: 557–563 FI 2,941

Bayoumi A, Jalil I, Metwally M, Adams LA, Aller R, García-Monzón C, Arias-Loste MT, Miele L, Petta S, Craxì A, Gallego-Durán R, Fischer J, Berg T, Qiao L , Liddle C, Bugianesi E, Romero-Gomez M, George J, Eslam M. Genetic variation in the TLL1 gene is not associated with fibrosis in patients with metabolic associated fatty liver disease. PLoS One. 2020 Dec 11; 15 (12): e0243590. doi: 10.1371 / journal.pone.0243590. PMID: 33306709; PMCID: PMC7732106.

Sicras-Mainar A, Aller R, Crespo J, Calleja JL, Turnes J, Romero-Gómez M, Augustín S. Overall clinical and economic impact of non-alcoholic fatty liver disease. Rev Esp Enferm Dig. 2020 Nov 23. doi: 17235 / reed.2020.7238 / 2020. Epub ahead of print. PMID: 33222473.

Hardy T, Wonders K, Younes R, Aithal GP, Aller R, Allison M, Bedossa P, Betsou F, Boursier J, Brosnan MJ, Burt A, Cobbold J, Cortez-Pinto H, Day CP, Dufour JF, Ekstedt M, Francque S, Harrison S, Miele L, Nasr P, Papatheodoridis G, Petta S, Tiniakos D, Torstenson R, Valenti L, Holleboom AG, Yki-Jarvinen H, Geier A, Romero-Gomez M, Ratziu V, Bugianesi E, Schattenberg JM, Anstee QM; LITMUS Consortium. The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease. Contemp Clin Trials. 2020 Nov; 98: 106175. doi: 10.1016 / j.cct.2020.106175. Epub 2020 Oct 9. PMID: 33045403.

Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Albillos A, Francés R , Fernández-Rodríguez C, Diago M, Soriano G, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Estévez P, Hernandez-Guerra M, Augustín S, Bañales J, Aspichueta P, Benlloch S, Rosales JM, Salmerón J, Turnes J, Romero-Gómez M; HEPAmet Registry. Erratum to: "Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH (J Hepatol 2020; 73: 17-25). J Hepatol. 2020 Sep; 73 (3): 740-741. Doi: 10.1016 / j.jhep.2020.06.018. Epub 2020 Jul 9. Erratum for: J Hepatol. 2020 Jul; 73 (1): 17-25.

Gómez-Hurtado I, Gallego-Durán R, Zapater P, Ampuero J, Aller R, Crespo J, Arias-Loste M, García-Monzón C, Bellot P, González-Rodríguez Á, Juanola O, Romero-Gómez M , French R. Bacterial antigen translocation and age as BMI- independent contributing factors on systemic inflammation in NAFLD patients. Liver Int. 2020 Sep; 40 (9): 2182-2193.

Ampuero J, Aller R, Gallego-Durán R, Crespo J, Calleja JL, García-Monzón C, Gómez-Camarero J, Caballería J, Lo Iacono O, Ibañez L, García-Samaniego J, Albillos A, Francés R , Fernández-Rodríguez C, Diago M, Soriano G, Andrade RJ, Latorre R, Jorquera F, Morillas RM, Escudero D, Estévez P, Guerra MH, Augustín S, Banales JM, Aspichueta P, Benlloch S, Rosales JM, Salmerón J , Turnes J, Romero Gómez M; HEPAmet Registry. Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. J Hepatol. 2020 Jul; 73 (1): 17-25.

Calzadilla-Bertot L, Vilar-Gomez E, Wong VW, Romero-Gomez M, Aller-de la Fuente R, Wong GL, Castellanos M, Eslam M, Desai AP, Jeffrey GP, George J, Chalasani N, Adams THE. ABIDE: an accurate predictive model of liver decompensation in patients with non-alcoholic fatty liver-related cirrhosis. Hepatology. 2020 Sep 25. doi: 10.1002 / hep.31576. Epub ahead of print. PMID: 32978796.

Vilar-Gomez E, Calzadilla-Bertot L, Wong VW, Castellanos M, Aller-de la Fuente R, Eslam M, Wong GL, George J, Romero-Gomez M, Adams LA. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis. Clin Gastroenterol Hepatol. 2021 Jan; 19 (1): 136-145.e6. doi: 10.1016 / j.cgh.2020.04.083. Epub 2020 May 8. PMID: 32389886.